JP Patent

JP6422464B2 — レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤

Assigned to エルメッド エーザイ株式会社 · Expires 2018-11-14 · 8y expired

What this patent protects

Patent listed against Keppra.

Drugs covered by this patent

Patent Metadata

Patent number
JP6422464B2
Jurisdiction
JP
Classification
—
Expires
2018-11-14
Drug substance claim
No
Drug product claim
No
Assignee
エルメッド エーザイ株式会社
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.